Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-03

Clinical Trial Update: Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study is evaluating the effect of empagliflozin on left atrial function in adults at risk for heart failure, with recruitment ongoing. The trial is sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empagliflozin (empagliflozin)

Snippet

Sponsor: University of Minnesota | Conditions: Hypertension, Cardiovascular Diseases | EARLY_Phase 1 | Status: RECRUITING